Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on July 24, 2026

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
AI-Powered Wound Care Market Poised for Revolutionary Disruption as Investment Activity Surges
Allsup Highlights SSDI Barriers And Progress On ADA’s 36th Anniversary
Flight Simulator Market to Reach USD 9.77 Billion by 2031, Growing at 8.0% CAGR, Says MarketsandMarkets™
Next-Gen DTC Infrastructure: Spira Unveils Enterprise AI Influencer Platform to Combat Content Deficits and Elevate Storefront Growth
ZEELOOL Celebrates 9th Anniversary With Frames Up to 80% Off and Exclusive Style Experiences
Dr. Ekta Pandya Named Fellow of Pierre Fauchard Academy, Recognized for Leadership in Dentistry and Children's Oral Health
Following Reopened National Advertising Division Matter, Willow Health Services Voluntarily Discontinues Claims for Compounded Semaglutide Products
Changan Named to Kantar BrandZ Top 50 Chinese Global Brand Builders for Three Consecutive Years
WSP confirme avoir présenté à Arcadis N.V. une déclaration d’intérêt indicative non contraignante visant l’acquisition de toutes les actions émises et en circulation du capital-actions d’Arcadis N.V. moyennant un prix d’offre de 51,50 euros par actio…
WellSpan Health Awarded $2.8 million to Strengthen Care at Rural Hospitals
Camli Opens Premium Cabin Consultation for U.S. Travelers as International Booking Windows for the 2026-27 Season Go Live
Quantum X Labs Reports Meaningful Error Correction Decoder Results with NVIDIA CUDA-Q QEC
Factorial Secures First Commercial Aerospace Order for Advanced Battery Cells
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
Yoroll Launches AI Odyssey, a Playable AI Film Inspired by Homer's Epic
WSP confirms submission of non-binding indicative expression of interest to Arcadis N.V. to acquire all issued and outstanding shares in the capital of Arcadis N.V. for an offer price of EUR 51.50 per share
Subcutaneous PD-1 Inhibitors Transition from Novelty to Routine Care as Oncologists Tailor Use by Tumor Type, According to Spherix Global Insights
EBC führt TradingView Professional Charts mit kostenlosem Zugang zu Premium-Indikatoren ein
EBC lanza gráficos profesionales de TradingView con acceso gratuito a indicadores premium

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Chemicals Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.